Leaflet ELOQUINE 250mg tablets

Product code:
W54015001
Quantity:
100
Indicated for:
malaria
Route of administration:
oral
Substance:
mefloquine (antimalarial)
ATC
P01BC02 — Antiparasitic products, insecticides and repellents | Antimalarials | Methanolquinolines
Mefloquine is a medication used for the prevention and treatment of malaria. It is effective against several Plasmodium species, including Plasmodium falciparum, which is responsible for severe forms of malaria.

This medication is taken orally, usually once a week for prophylaxis or according to a specific regimen for treatment. It is important to start taking it at least one week before traveling to an endemic area and to continue for several weeks after returning.

Mefloquine may cause side effects such as nausea, dizziness, or sleep disturbances. In rare cases, neuropsychiatric reactions such as anxiety or depression may occur. Patients with a history of psychiatric disorders should avoid using this medication.

To ensure effectiveness, it is essential to follow the dosing schedule and consult a doctor before use, especially if taking other medications.

General data about ELOQUINE 250mg

Substance:
mefloquine
Date of latest medicines list:
01-09-2022
Product code:
W54015001
Concentration:
250mg
Pharmaceutical form:
tablets
Quantity:
100
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
MEDOCHEMIE LTD. - CIPRU
Holder:
CN UNIFARM S.A. - ROMANIA
Number:
515/2020/01
Shelf life:
60 months

Pharmaceutical forms available for mefloquine